Therefore, it is conjectured that dysregulated instigation of NLRP3 may influence the advancement of chronic lung diseases such as IPF, asthma, and chronic obstructive pulmonary disease [51]. This evidence concerns the gene NLRP3 and idiopathic pulmonary fibrosis.